首页> 外文期刊>Annual Review of Pharmacology and Toxicology >High-throughput screening in drug metabolism and pharmacokinetic support of drug discovery.
【24h】

High-throughput screening in drug metabolism and pharmacokinetic support of drug discovery.

机译:药物代谢中的高通量筛选和药物发现的药代动力学支持。

获取原文
获取原文并翻译 | 示例

摘要

The application of rapid methods currently used for screening discovery drug candidates for metabolism and pharmacokinetic characteristics is discussed. General considerations are given for screening in this context, including the criteria for good screens, the use of counterscreens, the proper sequencing of screens, ambiguity in the interpretation of results, strategies for false positives and negatives, and the special difficulties encountered in drug metabolism and pharmacokinetic screening. Detailed descriptions of the present status of screening are provided for absorption potential, blood-brain barrier penetration, inhibition and induction of cytochrome P450, pharmacokinetics, biotransformation, and computer modeling. Although none of the systems currently employed for drug metabolism and pharmacokinetic screening can be considered truly high-throughput, several of them are rapid enough to be a practical part of the screening paradigm for modern, fast-moving discovery programs.
机译:讨论了目前用于筛选发现的候选药物的代谢和药代动力学特征的快速方法的应用。在此背景下进行筛查时应考虑一般因素,包括良好筛查的标准,使用反向筛查的方法,筛查的正确顺序,结果解释的歧义,假阳性和阴性的策略以及药物代谢中遇到的特殊困难和药代动力学筛选。提供了筛选当前状态的详细描述,包括吸收潜力,血脑屏障渗透,细胞色素P450的抑制和诱导,药代动力学,生物转化和计算机建模。尽管当前没有将用于药物代谢和药代动力学筛选的系统视为真正的高通量,但是其中一些系统足够快,足以成为现代快速发展的发现计划筛选范例的实际组成部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号